Activest Wealth Management’s Nanobiotix NBTX Stock Holding History

Activest Wealth Management’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-283	Closed	-$1.04K	–	456
2022 Q4	$1.04K	Hold	283	–	–	﹤0.01%	421
2022 Q3	$1K	Hold	283	–	–	﹤0.01%	413
2022 Q2	$1K	Hold	283	–	–	﹤0.01%	361
2022 Q1	$2K	Hold	283	–	–	﹤0.01%	303
2021 Q4	$2K	Hold	283	–	–	﹤0.01%	300
2021 Q3	$3K	Hold	283	–	–	﹤0.01%	316
2021 Q2	$4K	Hold	283	–	–	﹤0.01%	274
2021 Q1	$4K	Buy	+283	New	+$4.86K	﹤0.01%	248

Other funds holding NBTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Activest Wealth Management's NBTX Position: Q1 2023 in Review

Activest Wealth Management sold out of Nanobiotix (NBTX) in Q1 2023, closing a stake of 283 shares — an estimated $1.04K sold.

Activest Wealth Management first reported a position in NBTX in Q1 2021 and held it in 8 quarters. The position peaked at $4K in Q2 2021. 4 funds tracked by Wall St. Rank hold NBTX as of Q1 2023.

Activest Wealth Management reported no remaining Nanobiotix position as of Q1 2023 after selling out during the quarter.
Activest Wealth Management sold 283 Nanobiotix shares in Q1 2023, an estimated $1.04K.
Activest Wealth Management first reported a position in Nanobiotix in Q1 2021 and held it in 8 quarters.
Activest Wealth Management's Nanobiotix position peaked at $4K in Q2 2021.
4 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2023.

Based on Activest Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.